JP2004244409A5 - - Google Patents

Download PDF

Info

Publication number
JP2004244409A5
JP2004244409A5 JP2003200333A JP2003200333A JP2004244409A5 JP 2004244409 A5 JP2004244409 A5 JP 2004244409A5 JP 2003200333 A JP2003200333 A JP 2003200333A JP 2003200333 A JP2003200333 A JP 2003200333A JP 2004244409 A5 JP2004244409 A5 JP 2004244409A5
Authority
JP
Japan
Prior art keywords
group
amino
alkyl group
ethyl
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003200333A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004244409A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2004244409A publication Critical patent/JP2004244409A/ja
Publication of JP2004244409A5 publication Critical patent/JP2004244409A5/ja
Withdrawn legal-status Critical Current

Links

JP2003200333A 2002-07-23 2003-07-23 糖尿病の発症予防薬 Withdrawn JP2004244409A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002213898 2002-07-23
JP2002366844 2002-12-18

Publications (2)

Publication Number Publication Date
JP2004244409A JP2004244409A (ja) 2004-09-02
JP2004244409A5 true JP2004244409A5 (https=) 2006-08-31

Family

ID=30772237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003200333A Withdrawn JP2004244409A (ja) 2002-07-23 2003-07-23 糖尿病の発症予防薬

Country Status (6)

Country Link
US (1) US20050187194A1 (https=)
EP (1) EP1535630A1 (https=)
JP (1) JP2004244409A (https=)
AU (1) AU2003252676A1 (https=)
TW (1) TW200409643A (https=)
WO (1) WO2004009118A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144308A1 (en) * 2001-09-24 2003-07-31 Bauer Paul H. Fructose 1,6-bisphosphatase inhibitors
JP2008510018A (ja) * 2004-08-18 2008-04-03 メタバシス・セラピューティクス・インコーポレイテッド フルクトース−1,6−ビスホスファターゼの新規チアゾール阻害物質
BRPI0519006A2 (pt) * 2004-12-13 2008-12-23 Daiichi Sankyo Co Ltd uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos
EP1825854A1 (en) * 2004-12-15 2007-08-29 Daiichi Sankyo Company, Limited MEDICINAL COMPOSITION CONTAINING FBPase INHIBITOR
WO2007129522A1 (ja) * 2006-04-10 2007-11-15 Daiichi Sankyo Company, Limited 乾式製造法製剤
EP2032548A1 (en) 2006-06-01 2009-03-11 F.Hoffmann-La Roche Ag Thiazole derivatives
US20100076037A1 (en) 2006-11-02 2010-03-25 Chiang Lillian W Methods of Treating Neuropathic Pain with Agonists of PPAR-gamma
EP2227452A2 (en) 2007-11-30 2010-09-15 F. Hoffmann-La Roche AG Pyridine compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047549A1 (en) * 1998-03-16 1999-09-23 Ontogen Corporation PIPERAZINES AS INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE (FBPase)
KR100818845B1 (ko) * 1998-09-09 2008-04-01 메타베이시스 테라퓨틱스, 인크. 신규한 프럭토스 1,6-비스포스파타제의 헤테로방향족 억제제
US6756360B1 (en) * 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
AU784370B2 (en) * 1999-12-22 2006-03-23 Metabasis Therapeutics, Inc. Novel bisamidate phosphonate prodrugs
JP2003525944A (ja) * 2000-03-08 2003-09-02 メタバシス・セラピューティクス・インコーポレイテッド 新規アリールフルクトース−1,6−ビスホスファターゼ阻害剤
US6821509B2 (en) * 2000-04-14 2004-11-23 Cosmetica, Inc. Nanoscopic hair care products
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) * 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin

Similar Documents

Publication Publication Date Title
AU780678B2 (en) New use of compounds as antibacterial agents
CN101389352B (zh) 治疗或预防消化道溃疡的药物
JP2008514732A5 (https=)
JP2024119812A5 (https=)
JP2009534386A5 (https=)
JP2002520416A5 (https=)
JP2011527335A5 (https=)
JP2011527334A5 (https=)
CA2565813A1 (en) Substituted methyl aryl or heteroaryl amide compounds
RU2003126233A (ru) Конденсированные циклические соединения и их использование в медицине
JP2005504053A5 (https=)
JP2007529421A5 (https=)
KR20040025915A (ko) 디펩티딜 펩티다아제 iv의 저해제를 이용한 2형당뇨병의 치료
JP2003500442A5 (https=)
JP2020512337A5 (https=)
JP2011500506A5 (https=)
JP2006506443A5 (https=)
JP2005526696A5 (https=)
JP2007520452A5 (https=)
JP2004244409A5 (https=)
JP2010522218A5 (https=)
JP2004524279A5 (https=)
RU2011141794A (ru) Амидное производное
JP2005526732A5 (https=)
EA019037B1 (ru) 5-[5-[2-[3,5-бис(трифторметил)фенил-2-метилпропаноилметиламино]-4-(4-фтор-2-метилфенил)]-2-пиридинил]-2-алкилпролинамиды в качестве антагонистов рецептора nk1